Company
Shanghai Cell Therapy Group Co.,Ltd
Shanghai Cell Therapy Group Co.,Ltd has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| CD19/CD22/BCMA CAR-T cells(BZE2204) | Phase 1 | Idiopathic Inflammatory Myopathies(IIM) |
Latest
No recent events.
Follow Shanghai Cell Therapy Group Co.,Ltd on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.